These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA. Roberts AL; Howarth GS; Liaw WC; Moretta S; Kritas S; Lymn KA; Yazbeck R; Tran C; Fletcher JM; Butler RN; Byers S J Cell Physiol; 2009 May; 219(2):259-64. PubMed ID: 19170061 [TBL] [Abstract][Full Text] [Related]
28. Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III). White KK; Karol LA; White DR; Hale S J Pediatr Orthop; 2011; 31(5):594-8. PubMed ID: 21654471 [TBL] [Abstract][Full Text] [Related]
29. [Prenatal diagnosis of Sanfilippo A disease (mucopolysaccharidosis IIIA)]. Török O; Váradi V; Szondy M; Molnár M; Szabó M; Papp Z Orv Hetil; 1986 Sep; 127(39):2385-7. PubMed ID: 3095766 [No Abstract] [Full Text] [Related]
31. Sanfilippo A disease in the fetus--comparison with pre- and postnatal cases. Ceuterick C; Martin JJ; Libert J; Farriaux JP Neuropadiatrie; 1980 May; 11(2):176-85. PubMed ID: 6777713 [TBL] [Abstract][Full Text] [Related]
32. Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice. Hemsley KM; King B; Hopwood JJ Mol Genet Metab; 2007 Mar; 90(3):313-28. PubMed ID: 17166757 [TBL] [Abstract][Full Text] [Related]
33. Sanfilippo B syndrome (MPS III B): case report with analysis of CSF mucopolysaccharides and conjunctival biopsy. Federico A; Capece G; Cecio A; D'Auria N; Di Iorio G; Ronsisvalle L; Di Natale P J Neurol; 1981; 225(2):77-83. PubMed ID: 6164767 [TBL] [Abstract][Full Text] [Related]
34. Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA. Roberts AL; Rees MH; Klebe S; Fletcher JM; Byers S Mol Genet Metab; 2007; 92(1-2):115-21. PubMed ID: 17681480 [TBL] [Abstract][Full Text] [Related]
35. Sanfilippo syndrome: a case report of mucopolysaccharidosis III A. Cho S; Pennington K; Thomas GH J Kans Med Soc; 1979 Sep; 80(9):494-8. PubMed ID: 117063 [No Abstract] [Full Text] [Related]
36. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA). Hemsley KM; Hopwood JJ Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885 [TBL] [Abstract][Full Text] [Related]
37. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Weber B; Guo XH; Kleijer WJ; van de Kamp JJ; Poorthuis BJ; Hopwood JJ Eur J Hum Genet; 1999 Jan; 7(1):34-44. PubMed ID: 10094189 [TBL] [Abstract][Full Text] [Related]
38. Mild Sanfilippo syndrome: a further cause of hyperactivity and behavioural disturbance. Wraith JE; Danks DM; Rogers JG Med J Aust; 1987 Nov; 147(9):450-1. PubMed ID: 3118155 [TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Yogalingam G; Hopwood JJ Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611 [TBL] [Abstract][Full Text] [Related]
40. Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice. Lau AA; Crawley AC; Hopwood JJ; Hemsley KM Behav Brain Res; 2008 Aug; 191(1):130-6. PubMed ID: 18453006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]